Psoriasis Drug Shows Promise in Treating Type 1 Diabetes
A drug that has previously been used to treat psoriasis, a skin condition, has shown promising results for potentially treating type 1 diabetes. The drug is an immune-suppressing agent called alefacept. Previously it was thought that the disadvantages of using an immunosuppressant long term far outweighed the benefits. Recent immunosuppressant drugs, however, have been developed to target specific cells which trigger autoimmune disorders, yet avoid the cells needed for normal functioning of the immune system.